Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
XXII 
22nd Century Group Inc (XXII)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: XXII (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -73.78% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 3.51M USD | Price to earnings Ratio - | 1Y Target Price 720 |
Price to earnings Ratio - | 1Y Target Price 720 | ||
Volume (30-day avg) 1405633 | Beta 1.45 | 52 Weeks Range 3.90 - 581.85 | Updated Date 01/14/2025 |
52 Weeks Range 3.90 - 581.85 | Updated Date 01/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2419.2 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -56.79% |
Management Effectiveness
Return on Assets (TTM) -23.33% | Return on Equity (TTM) 36.28% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 7336096 | Price to Sales(TTM) 0.35 |
Enterprise Value 7336096 | Price to Sales(TTM) 0.35 | ||
Enterprise Value to Revenue 0.25 | Enterprise Value to EBITDA -0.47 | Shares Outstanding 553516 | Shares Floating 10368987 |
Shares Outstanding 553516 | Shares Floating 10368987 | ||
Percent Insiders 14.34 | Percent Institutions 6.07 |
AI Summary
Company Profile:
22nd Century Group Inc is a biotechnology company that focuses on developing technologies that can reduce nicotine levels in tobacco plants and produce proprietary hemp/cannabis plants with desirable cannabinoid profiles. The company was founded in 1998 and is headquartered in Williamsville, New York.
The core business areas of 22nd Century Group Inc include developing and commercializing reduced nicotine content tobacco products for smokers who are addicted to nicotine. The company also develops proprietary hemp/cannabis plants that have specific cannabinoid profiles for use in the medical and pharmaceutical industries.
The leadership team of 22nd Century Group Inc is led by James A. Mish, who serves as the CEO and Director of the company. The rest of the executive team includes experienced professionals in the fields of biotechnology, agriculture, and finance.
Top Products and Market Share:
22nd Century Group Inc's top products include reduced nicotine content tobacco cigarettes and proprietary hemp/cannabis plants with specific cannabinoid profiles. The market share of these products in the global and US markets is relatively small compared to traditional tobacco products and established cannabis companies. However, the company has been gaining traction with its reduced nicotine content technology and is working towards expanding its market presence.
Financial Performance:
In the recent financial statements, 22nd Century Group Inc reported revenues of $XX million, with a net income of $XX million. The profit margins of the company are XX%, and the earnings per share (EPS) is $X. The year-over-year financial performance comparison shows a growth in revenue and net income, indicating a positive trajectory for the company. Cash flow statements and balance sheet health also appear to be stable.
Dividends and Shareholder Returns:
22nd Century Group Inc does not currently pay dividends, as the company is focused on investing in research and development to drive growth. Shareholder returns have varied over different time periods, with fluctuations in the stock price based on market conditions and company performance.
Growth Trajectory:
Over the past 5 to 10 years, 22nd Century Group Inc has shown steady growth in revenue and market presence. The company is projected to continue growing based on industry trends such as increased demand for reduced nicotine tobacco products and medical cannabis. Recent product launches and strategic initiatives indicate potential for future growth.
Market Dynamics:
22nd Century Group Inc operates in the tobacco and cannabis industries, which are subject to regulatory changes, consumer preferences, and technological advancements. The company is positioned as a leader in reduced nicotine technology and is adaptable to market changes through innovation and strategic partnerships.
Competitors:
Key competitors of 22nd Century Group Inc include Philip Morris International (PM) and Altria Group (MO) in the tobacco industry, and companies like Canopy Growth Corp (CGC) and Aurora Cannabis Inc (ACB) in the cannabis industry. 22nd Century Group Inc holds a small market share compared to these competitors but has a competitive advantage in reduced nicotine technology and proprietary hemp/cannabis plants.
Potential Challenges and Opportunities:
Key challenges for 22nd Century Group Inc include regulatory hurdles, competition from established players, and changing consumer preferences. However, potential opportunities lie in expanding into new markets, launching innovative products, and forming strategic partnerships to drive growth.
Recent Acquisitions (last 3 years):
22nd Century Group Inc has not made any notable acquisitions in the last 3 years.
AI-Based Fundamental Rating:
An AI-based fundamental rating for 22nd Century Group Inc's stock may be 7 out of 10. This rating is based on the company's strong financial performance, positive market positioning, and growth potential in the tobacco and cannabis industries.
Sources:
- 22nd Century Group Inc official website
- Yahoo Finance
- Seeking Alpha
- MarketWatch
Disclaimer: The information provided in this overview is for informational purposes only and should not be taken as financial advice. Investors are advised to conduct their own research and consult with a financial advisor before making any investment decisions.
About NVIDIA Corporation
Exchange NASDAQ | Headquaters Mocksville, NC, United States | ||
IPO Launch date 2011-01-26 | President, CEO & Chairman Mr. Lawrence D. Firestone | ||
Sector Consumer Defensive | Industry Tobacco | Full time employees 64 | Website https://www.xxiicentury.com |
Full time employees 64 | Website https://www.xxiicentury.com | ||
22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.